Home › Funds › D. E. Shaw & Co › NRIX
D. E. Shaw & Co position in NRIX
NURIX THERAPEUTICS INC · Health Care
Latest position (Q2 2026)184.55K sh
Reported value held$4.48M
Portfolio Weight0.00%
First reportedQ3 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 60.01K | $782.00K | New |
| Q4 2022 | 91.71K | $1.01M | Add |
| Q1 2023 | 59.04K | $524.25K | Reduce |
| Q2 2023 | 51.50K | $514.50K | Reduce |
| Q3 2023 | 25.36K | $199.31K | Reduce |
| Q3 2024 | 72.84K | $1.64M | New |
| Q4 2024 | 112.84K | $2.13M | Add |
| Q1 2025 | 59.92K | $711.88K | Reduce |
| Q1 2026 | 344.20K | $5.34M | New |
| Q2 2026 | 184.55K | $4.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- Geode Capital Management 2.54M sh · $61.57M · Q2 2026
- ARK Invest 1.79M sh · $43.50M · Q2 2026
- Capital World Investors 1.79M sh · $43.37M · Q2 2026
- Citadel Advisors 1.53M sh · $37.10M · Q2 2026
- UBS Group AG 917.12K sh · $22.25M · Q2 2026
- Northern Trust Corp 876.07K sh · $21.25M · Q2 2026
- Bank of America Corp 842.09K sh · $20.43M · Q2 2026
- Charles Schwab Investment Management 833.30K sh · $20.22M · Q2 2026